Hera BioLabs

Hera Biolabs, Inc., based in Lexington, KY is an innovative preclinical contract services, products and licensing company. The company's mission is to use cutting-edge gene-editing technologies to accelerate preclinical research and drug and cell-based therapeutic discovery and development. Hera built the SRG platform, an immunocompromised double k... nockout Sprague-Dawley rat engineered for T-cell, B-cell, and NK cell deficiency. The company's first established commercial model is the SRG OncoRat, a valuable complement or alternative to oncology studies in mice, and well suited for xenograft oncology studies given its excellent tumor take-rates, large tumor mass, and smooth transition from efficacy to safety. Hera sells the SRG OncoRat to researchers and has been conducting oncology/pharmacology studies for clients over the past 5 years. Using immunocompromised husbandry procedures, the company's experienced staff performs studies in the company's on-site state-of-the-art vivarium that features dual HEPA-filtered, disposable IVC rodent caging systems. We're also continuing to use the company's proprietary Cas-CLOVER CRISPR system and piggyBac gene-editing technologies and know-how to expand the company's robust pipeline of models and services.Read More